AVIVA PLC - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 81 filers reported holding Y-MABS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
AVIVA PLC ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$1,160,000
-28.9%
38,351
+16.4%
0.01%
-25.0%
Q4 2020$1,632,000
-28.8%
32,953
-44.8%
0.01%
-42.9%
Q3 2020$2,291,000
+5.6%
59,667
+18.8%
0.01%0.0%
Q2 2020$2,169,000
-37.3%
50,206
-62.1%
0.01%
-44.0%
Q1 2020$3,461,000132,6130.02%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 2,104,278$54,837,0004.96%
Cormorant Asset Management, LP 883,800$23,032,0001.40%
SPHERA FUNDS MANAGEMENT LTD. 190,000$4,951,0000.76%
Perceptive Advisors 854,940$22,280,0000.60%
Artal Group S.A. 400,000$10,424,0000.42%
DRIEHAUS CAPITAL MANAGEMENT LLC 207,089$5,397,0000.18%
Vident Investment Advisory, LLC 64,571$1,683,0000.15%
Tuttle Capital Management, LLC 11,618$309,0000.08%
Baker Brothers Advisors 102,800$2,679,0000.02%
AXA S.A. 311,010$8,104,0000.02%
View complete list of Y-MABS THERAPEUTICS INC shareholders